BioRem Inc. (BRM.V)
| Previous Close | 0.9600 |
| Open | 0.9200 |
| Bid | 0.9500 x 0 |
| Ask | 1.0100 x 0 |
| Day's Range | 0.9200 - 0.9600 |
| 52 Week Range | 0.8000 - 1.1000 |
| Volume | |
| Avg. Volume | 4,430 |
| Market Cap | 15.07M |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | 24.00 |
| EPS (TTM) | 0.0400 |
| Earnings Date | Nov 28, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
CNW GroupBiorem Reports Second Quarter Results and Record Order Backlog
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2023. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
CNW GroupBiorem Announces Stock Option Grant
Biorem Inc. (TSXV: BRM) ("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.01 per share for a period of ten years from the date of grant.
